STOCK TITAN
  1. Home
  2. News
  3. ALPMY

Astellas Pharma Inc. - ALPMY STOCK NEWS

IMPACT
SENTIMENT
SGEN : Nasdaq ALPMY : OTC
Seagen and Astellas Announce Initial Results of PADCEV® (enfortumab vedotin-ejfv) in Patients With Muscle-Invasive Bladder Cancer Not Eligible for Cisplatin Chemotherapy
IMPACT
SENTIMENT
ALPMY : OTC
Astellas Announces Positive Safety Data from the FORTIS Study of AT845 in Adults with Late-Onset Pompe Disease
IMPACT
SENTIMENT
SGEN : Nasdaq ALPMY : OTC
Astellas and Seagen Receive Positive CHMP Opinion for PADCEV™ (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer
IMPACT
SENTIMENT
ALPMY : OTC SGEN : Nasdaq
Astellas and Seagen Receive Positive CHMP Opinion for PADCEV™ (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer
IMPACT
SENTIMENT
ALPMY : OTC
Astellas and MBC BioLabs Announce Future Innovator Prize Winners - Helping Biotech Start-ups Accelerate Early Research Efforts
IMPACT
SENTIMENT
ALPMY : OTC
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
IMPACT
SENTIMENT
ALPMY : OTC
Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia - from Diagnosis to Relapse - at 2021 American Society of Hematology Annual Meeting
conferences
IMPACT
SENTIMENT
ALPMY : OTC
Astellas and LabCentral Announce Future Innovator Prize Winners - Helping Emerging Biotechs Accelerate Growth of Innovative Science
IMPACT
SENTIMENT
SGEN : Nasdaq ALPMY : OTC
Seagen and Astellas Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® (enfortumab vedotin-ejfv) With Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer
IMPACT
SENTIMENT
ALPMY : OTC SGEN : Nasdaq
Astellas and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® (enfortumab vedotin-ejfv) with Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer
Stock ALPMY logo
Astellas Pharma Inc.

Nasdaq:ALPMY

ALPMY Rankings

#575 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

ALPMY Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link
Pharmaceuticals: Other, Health Technology, Manufacturing, Medicinal and Botanical Manufacturing
Japan
Chuo Ku